Click for best price
Lung Disease Therapeutic Drug Market Size, Share 2024
The global Lung Disease Therapeutic Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Corticosteroids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Lung Disease Therapeutic Drug include GSK, AstraZeneca, Boehringer Ingelheim, Novartis, Mylan, Vertex Pharmaceuticals, F. Hoffman La Roche, Teva Pharmaceuticals and Cipla, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Lung Disease Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Disease Therapeutic Drug. This report contains market size and forecasts of Lung Disease Therapeutic Drug in global, including the following market information:
Global Lung Disease Therapeutic Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Lung Disease Therapeutic Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Lung Disease Therapeutic Drug companies in 2023 (%)
We surveyed the Lung Disease Therapeutic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Disease Therapeutic Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Lung Disease Therapeutic Drug Market Segment Percentages, by Type, 2023 (%)
Corticosteroids
Bronchodilator Medications
Mucolytics
Antimicrobial Medications
Others
Global Lung Disease Therapeutic Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Lung Disease Therapeutic Drug Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Lung Disease Therapeutic Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Lung Disease Therapeutic Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lung Disease Therapeutic Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Lung Disease Therapeutic Drug revenues share in global market, 2023 (%)
Key companies Lung Disease Therapeutic Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Lung Disease Therapeutic Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lung Disease Therapeutic Drug, market overview.
Chapter 2: Global Lung Disease Therapeutic Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Lung Disease Therapeutic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lung Disease Therapeutic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lung Disease Therapeutic Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Lung Disease Therapeutic Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Disease Therapeutic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Disease Therapeutic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Disease Therapeutic Drug Overall Market Size
2.1 Global Lung Disease Therapeutic Drug Market Size: 2023 VS 2030
2.2 Global Lung Disease Therapeutic Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Lung Disease Therapeutic Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Lung Disease Therapeutic Drug Players in Global Market
3.2 Top Global Lung Disease Therapeutic Drug Companies Ranked by Revenue
3.3 Global Lung Disease Therapeutic Drug Revenue by Companies
3.4 Global Lung Disease Therapeutic Drug Sales by Companies
3.5 Global Lung Disease Therapeutic Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Lung Disease Therapeutic Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Lung Disease Therapeutic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lung Disease Therapeutic Drug Players in Global Market
3.8.1 List of Global Tier 1 Lung Disease Therapeutic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Lung Disease Therapeutic Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Lung Disease Therapeutic Drug Market Size Markets, 2023 & 2030
4.1.2 Corticosteroids
4.1.3 Bronchodilator Medications
4.1.4 Mucolytics
4.1.5 Antimicrobial Medications
4.1.6 Others
4.2 By Type - Global Lung Disease Therapeutic Drug Revenue & Forecasts
4.2.1 By Type - Global Lung Disease Therapeutic Drug Revenue, 2019-2024
4.2.2 By Type - Global Lung Disease Therapeutic Drug Revenue, 2025-2030
4.2.3 By Type - Global Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Lung Disease Therapeutic Drug Sales & Forecasts
4.3.1 By Type - Global Lung Disease Therapeutic Drug Sales, 2019-2024
4.3.2 By Type - Global Lung Disease Therapeutic Drug Sales, 2025-2030
4.3.3 By Type - Global Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
4.4 By Type - Global Lung Disease Therapeutic Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Disease Therapeutic Drug Market Size, 2023 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Lung Disease Therapeutic Drug Revenue & Forecasts
5.2.1 By Application - Global Lung Disease Therapeutic Drug Revenue, 2019-2024
5.2.2 By Application - Global Lung Disease Therapeutic Drug Revenue, 2025-2030
5.2.3 By Application - Global Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Lung Disease Therapeutic Drug Sales & Forecasts
5.3.1 By Application - Global Lung Disease Therapeutic Drug Sales, 2019-2024
5.3.2 By Application - Global Lung Disease Therapeutic Drug Sales, 2025-2030
5.3.3 By Application - Global Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
5.4 By Application - Global Lung Disease Therapeutic Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Lung Disease Therapeutic Drug Market Size, 2023 & 2030
6.2 By Region - Global Lung Disease Therapeutic Drug Revenue & Forecasts
6.2.1 By Region - Global Lung Disease Therapeutic Drug Revenue, 2019-2024
6.2.2 By Region - Global Lung Disease Therapeutic Drug Revenue, 2025-2030
6.2.3 By Region - Global Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Lung Disease Therapeutic Drug Sales & Forecasts
6.3.1 By Region - Global Lung Disease Therapeutic Drug Sales, 2019-2024
6.3.2 By Region - Global Lung Disease Therapeutic Drug Sales, 2025-2030
6.3.3 By Region - Global Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Lung Disease Therapeutic Drug Revenue, 2019-2030
6.4.2 By Country - North America Lung Disease Therapeutic Drug Sales, 2019-2030
6.4.3 US Lung Disease Therapeutic Drug Market Size, 2019-2030
6.4.4 Canada Lung Disease Therapeutic Drug Market Size, 2019-2030
6.4.5 Mexico Lung Disease Therapeutic Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Lung Disease Therapeutic Drug Revenue, 2019-2030
6.5.2 By Country - Europe Lung Disease Therapeutic Drug Sales, 2019-2030
6.5.3 Germany Lung Disease Therapeutic Drug Market Size, 2019-2030
6.5.4 France Lung Disease Therapeutic Drug Market Size, 2019-2030
6.5.5 U.K. Lung Disease Therapeutic Drug Market Size, 2019-2030
6.5.6 Italy Lung Disease Therapeutic Drug Market Size, 2019-2030
6.5.7 Russia Lung Disease Therapeutic Drug Market Size, 2019-2030
6.5.8 Nordic Countries Lung Disease Therapeutic Drug Market Size, 2019-2030
6.5.9 Benelux Lung Disease Therapeutic Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Lung Disease Therapeutic Drug Revenue, 2019-2030
6.6.2 By Region - Asia Lung Disease Therapeutic Drug Sales, 2019-2030
6.6.3 China Lung Disease Therapeutic Drug Market Size, 2019-2030
6.6.4 Japan Lung Disease Therapeutic Drug Market Size, 2019-2030
6.6.5 South Korea Lung Disease Therapeutic Drug Market Size, 2019-2030
6.6.6 Southeast Asia Lung Disease Therapeutic Drug Market Size, 2019-2030
6.6.7 India Lung Disease Therapeutic Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Lung Disease Therapeutic Drug Revenue, 2019-2030
6.7.2 By Country - South America Lung Disease Therapeutic Drug Sales, 2019-2030
6.7.3 Brazil Lung Disease Therapeutic Drug Market Size, 2019-2030
6.7.4 Argentina Lung Disease Therapeutic Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Lung Disease Therapeutic Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Lung Disease Therapeutic Drug Sales, 2019-2030
6.8.3 Turkey Lung Disease Therapeutic Drug Market Size, 2019-2030
6.8.4 Israel Lung Disease Therapeutic Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Lung Disease Therapeutic Drug Market Size, 2019-2030
6.8.6 UAE Lung Disease Therapeutic Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Lung Disease Therapeutic Drug Major Product Offerings
7.1.4 GSK Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.1.5 GSK Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Lung Disease Therapeutic Drug Major Product Offerings
7.2.4 AstraZeneca Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Major Product Offerings
7.3.4 Boehringer Ingelheim Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Lung Disease Therapeutic Drug Major Product Offerings
7.4.4 Novartis Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Mylan
7.5.1 Mylan Company Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Lung Disease Therapeutic Drug Major Product Offerings
7.5.4 Mylan Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.5.5 Mylan Key News & Latest Developments
7.6 Vertex Pharmaceuticals
7.6.1 Vertex Pharmaceuticals Company Summary
7.6.2 Vertex Pharmaceuticals Business Overview
7.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Major Product Offerings
7.6.4 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.6.5 Vertex Pharmaceuticals Key News & Latest Developments
7.7 F. Hoffman La Roche
7.7.1 F. Hoffman La Roche Company Summary
7.7.2 F. Hoffman La Roche Business Overview
7.7.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Major Product Offerings
7.7.4 F. Hoffman La Roche Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.7.5 F. Hoffman La Roche Key News & Latest Developments
7.8 Teva Pharmaceuticals
7.8.1 Teva Pharmaceuticals Company Summary
7.8.2 Teva Pharmaceuticals Business Overview
7.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Major Product Offerings
7.8.4 Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.8.5 Teva Pharmaceuticals Key News & Latest Developments
7.9 Cipla
7.9.1 Cipla Company Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Lung Disease Therapeutic Drug Major Product Offerings
7.9.4 Cipla Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.9.5 Cipla Key News & Latest Developments
7.10 Fibrogen
7.10.1 Fibrogen Company Summary
7.10.2 Fibrogen Business Overview
7.10.3 Fibrogen Lung Disease Therapeutic Drug Major Product Offerings
7.10.4 Fibrogen Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.10.5 Fibrogen Key News & Latest Developments
7.11 Liminal Biosciences
7.11.1 Liminal Biosciences Company Summary
7.11.2 Liminal Biosciences Lung Disease Therapeutic Drug Business Overview
7.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Major Product Offerings
7.11.4 Liminal Biosciences Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.11.5 Liminal Biosciences Key News & Latest Developments
7.12 PharmAkea Therapeutics
7.12.1 PharmAkea Therapeutics Company Summary
7.12.2 PharmAkea Therapeutics Lung Disease Therapeutic Drug Business Overview
7.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Major Product Offerings
7.12.4 PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.12.5 PharmAkea Therapeutics Key News & Latest Developments
7.13 IQVIA
7.13.1 IQVIA Company Summary
7.13.2 IQVIA Lung Disease Therapeutic Drug Business Overview
7.13.3 IQVIA Lung Disease Therapeutic Drug Major Product Offerings
7.13.4 IQVIA Lung Disease Therapeutic Drug Sales and Revenue in Global (2019-2024)
7.13.5 IQVIA Key News & Latest Developments
8 Global Lung Disease Therapeutic Drug Production Capacity, Analysis
8.1 Global Lung Disease Therapeutic Drug Production Capacity, 2019-2030
8.2 Lung Disease Therapeutic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Lung Disease Therapeutic Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lung Disease Therapeutic Drug Supply Chain Analysis
10.1 Lung Disease Therapeutic Drug Industry Value Chain
10.2 Lung Disease Therapeutic Drug Upstream Market
10.3 Lung Disease Therapeutic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lung Disease Therapeutic Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Lung Disease Therapeutic Drug in Global Market
Table 2. Top Lung Disease Therapeutic Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Lung Disease Therapeutic Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Lung Disease Therapeutic Drug Revenue Share by Companies, 2019-2024
Table 5. Global Lung Disease Therapeutic Drug Sales by Companies, (K Units), 2019-2024
Table 6. Global Lung Disease Therapeutic Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Lung Disease Therapeutic Drug Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Lung Disease Therapeutic Drug Product Type
Table 9. List of Global Tier 1 Lung Disease Therapeutic Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Disease Therapeutic Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Lung Disease Therapeutic Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Lung Disease Therapeutic Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Lung Disease Therapeutic Drug Sales (K Units), 2019-2024
Table 15. By Type - Global Lung Disease Therapeutic Drug Sales (K Units), 2025-2030
Table 16. By Application ? Global Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Lung Disease Therapeutic Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Lung Disease Therapeutic Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Lung Disease Therapeutic Drug Sales (K Units), 2019-2024
Table 20. By Application - Global Lung Disease Therapeutic Drug Sales (K Units), 2025-2030
Table 21. By Region ? Global Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Lung Disease Therapeutic Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Lung Disease Therapeutic Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Lung Disease Therapeutic Drug Sales (K Units), 2019-2024
Table 25. By Region - Global Lung Disease Therapeutic Drug Sales (K Units), 2025-2030
Table 26. By Country - North America Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Lung Disease Therapeutic Drug Sales, (K Units), 2019-2024
Table 29. By Country - North America Lung Disease Therapeutic Drug Sales, (K Units), 2025-2030
Table 30. By Country - Europe Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Lung Disease Therapeutic Drug Sales, (K Units), 2019-2024
Table 33. By Country - Europe Lung Disease Therapeutic Drug Sales, (K Units), 2025-2030
Table 34. By Region - Asia Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Lung Disease Therapeutic Drug Sales, (K Units), 2019-2024
Table 37. By Region - Asia Lung Disease Therapeutic Drug Sales, (K Units), 2025-2030
Table 38. By Country - South America Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Lung Disease Therapeutic Drug Sales, (K Units), 2019-2024
Table 41. By Country - South America Lung Disease Therapeutic Drug Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Lung Disease Therapeutic Drug Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Lung Disease Therapeutic Drug Sales, (K Units), 2025-2030
Table 46. GSK Company Summary
Table 47. GSK Lung Disease Therapeutic Drug Product Offerings
Table 48. GSK Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. GSK Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Lung Disease Therapeutic Drug Product Offerings
Table 52. AstraZeneca Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Boehringer Ingelheim Company Summary
Table 55. Boehringer Ingelheim Lung Disease Therapeutic Drug Product Offerings
Table 56. Boehringer Ingelheim Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Boehringer Ingelheim Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Lung Disease Therapeutic Drug Product Offerings
Table 60. Novartis Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Mylan Company Summary
Table 63. Mylan Lung Disease Therapeutic Drug Product Offerings
Table 64. Mylan Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Mylan Key News & Latest Developments
Table 66. Vertex Pharmaceuticals Company Summary
Table 67. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product Offerings
Table 68. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Vertex Pharmaceuticals Key News & Latest Developments
Table 70. F. Hoffman La Roche Company Summary
Table 71. F. Hoffman La Roche Lung Disease Therapeutic Drug Product Offerings
Table 72. F. Hoffman La Roche Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. F. Hoffman La Roche Key News & Latest Developments
Table 74. Teva Pharmaceuticals Company Summary
Table 75. Teva Pharmaceuticals Lung Disease Therapeutic Drug Product Offerings
Table 76. Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Teva Pharmaceuticals Key News & Latest Developments
Table 78. Cipla Company Summary
Table 79. Cipla Lung Disease Therapeutic Drug Product Offerings
Table 80. Cipla Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Cipla Key News & Latest Developments
Table 82. Fibrogen Company Summary
Table 83. Fibrogen Lung Disease Therapeutic Drug Product Offerings
Table 84. Fibrogen Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Fibrogen Key News & Latest Developments
Table 86. Liminal Biosciences Company Summary
Table 87. Liminal Biosciences Lung Disease Therapeutic Drug Product Offerings
Table 88. Liminal Biosciences Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Liminal Biosciences Key News & Latest Developments
Table 90. PharmAkea Therapeutics Company Summary
Table 91. PharmAkea Therapeutics Lung Disease Therapeutic Drug Product Offerings
Table 92. PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. PharmAkea Therapeutics Key News & Latest Developments
Table 94. IQVIA Company Summary
Table 95. IQVIA Lung Disease Therapeutic Drug Product Offerings
Table 96. IQVIA Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. IQVIA Key News & Latest Developments
Table 98. Lung Disease Therapeutic Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 99. Global Lung Disease Therapeutic Drug Capacity Market Share of Key Manufacturers, 2021-2024
Table 100. Global Lung Disease Therapeutic Drug Production by Region, 2019-2024 (K Units)
Table 101. Global Lung Disease Therapeutic Drug Production by Region, 2025-2030 (K Units)
Table 102. Lung Disease Therapeutic Drug Market Opportunities & Trends in Global Market
Table 103. Lung Disease Therapeutic Drug Market Drivers in Global Market
Table 104. Lung Disease Therapeutic Drug Market Restraints in Global Market
Table 105. Lung Disease Therapeutic Drug Raw Materials
Table 106. Lung Disease Therapeutic Drug Raw Materials Suppliers in Global Market
Table 107. Typical Lung Disease Therapeutic Drug Downstream
Table 108. Lung Disease Therapeutic Drug Downstream Clients in Global Market
Table 109. Lung Disease Therapeutic Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Lung Disease Therapeutic Drug Segment by Type in 2023
Figure 2. Lung Disease Therapeutic Drug Segment by Application in 2023
Figure 3. Global Lung Disease Therapeutic Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Lung Disease Therapeutic Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Lung Disease Therapeutic Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. Lung Disease Therapeutic Drug Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Lung Disease Therapeutic Drug Revenue in 2023
Figure 9. By Type - Global Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global Lung Disease Therapeutic Drug Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global Lung Disease Therapeutic Drug Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Lung Disease Therapeutic Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
Figure 23. US Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
Figure 28. Germany Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
Figure 37. China Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
Figure 44. Brazil Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Lung Disease Therapeutic Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Lung Disease Therapeutic Drug Sales Market Share, 2019-2030
Figure 48. Turkey Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Lung Disease Therapeutic Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global Lung Disease Therapeutic Drug Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Lung Disease Therapeutic Drug by Region, 2023 VS 2030
Figure 54. Lung Disease Therapeutic Drug Industry Value Chain
Figure 55. Marketing Channels
